Research progress on Epstein-Barr virus associated post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
10.3760/cma.j.issn.1009-9921.2012.08.019
- VernacularTitle:异基因造血干细胞移植后EB病毒相关性淋巴细胞增殖性疾病研究进展
- Author:
Chunli ZHANG
- Publication Type:Journal Article
- Keywords:
Lymphoproliferative disorders;
Allogeneic hematopoietic stem cell transplantation;
Epstein-Barr virus
- From:
Journal of Leukemia & Lymphoma
2012;21(8):504-507
- CountryChina
- Language:Chinese
-
Abstract:
Post-transplant lymphoproliferative disorders (PTLD) is one of the most potentially lifethreatening complications after allogeneic hematopoietic stem cell transplantation (a]lo-HSCT),and is mostly associated with Epstein-Barr virus infection.PTLD may have a wide range of clinical manifestations and pathological classifications.The rapid progression and high fatality of early PTLD should prompt clinicians to a timely diagnosis.This paper presents a review of the latest update on epidemiology,pathogenesis,clinical manifestations,diagnosis,management and prognosis of post allo-HSCT PTLD.
